Phenotypic Switching in a Cryptococcus neoformans Variety gattii Strain Is Associated with Changes in Virulence and Promotes Dissemination to the Central Nervous System
Open Access
- 1 February 2006
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 74 (2), 896-903
- https://doi.org/10.1128/iai.74.2.896-903.2006
Abstract
This is the first report of a Cryptococcus neoformans var. gattii strain (serotype B) that switches reversibly between its parent mucoid (NP1-MC) colony morphology and a smooth (NP1-SM) colony morphology. Similar to C. neoformans var. grubii and C. neoformans var. neoformans strains, the switch is associated with changes in the polysaccharide capsule and virulence in animal models. In murine infection models, NP1-MC is significantly more virulent than NP1-SM ( P < 0.021). In contrast to the serotype A and D strains, the serotype B strain switches in vivo reversibly between both colony morphologies. The polysaccharide of NP1-MC exhibits a thicker capsule, and thus NP1-MC exhibits enhanced intracellular survival in macrophages. Consistent with this finding, switching to the mucoid variant is observed in pulmonary infection with NP1-SM. In contrast, the thin polysaccharide capsule of NP1-SM permits better crossing of the blood-brain barrier. In this regard, only smooth colonies were grown from brain homogenates of NP1-MC-infected mice. Our findings have important implications for the pathogenesis of cryptococcosis and suggest that phenotypic switching affects host-pathogen interactions in the local microenvironment. This altered interaction then selects for specific colony variants to arise in a pathogen population.Keywords
This publication has 42 references indexed in Scilit:
- Molecular Epidemiology of Clinical Cryptococcus neoformans Strains from IndiaJournal of Clinical Microbiology, 2005
- Prevalence of Clinical Isolates ofCryptococcus gattiiSerotype C among Patients with AIDS in Sub‐Saharan AfricaThe Journal of Infectious Diseases, 2005
- Capsule Structure Changes Associated with Cryptococcus neoformans Crossing of the Blood-Brain BarrierThe American Journal of Pathology, 2005
- Effects of Antifungal Interventions on the Outcome of Experimental Infections with Phenotypic Switch Variants ofCryptococcus neoformansAntimicrobial Agents and Chemotherapy, 2005
- Cryptococcus neoformans infections at Vancouver Hospital and Health Sciences Centre (1997–2002): epidemiology, microbiology and histopathologyJournal of Medical Microbiology, 2004
- The damage-response framework of microbial pathogenesisNature Reviews Microbiology, 2003
- Trends in Antifungal Drug Susceptibility of Cryptococcus neoformans Isolates in the United States: 1992 to 1994 and 1996 to 1998Antimicrobial Agents and Chemotherapy, 2001
- Epidemiology and Host- and Variety-Dependent Characteristics of Infection Due to Cryptococcus neoformans in Australia and New ZealandClinical Infectious Diseases, 2000
- Epitope Location in the Cryptococcus neoformans Capsule Is a Determinant of Antibody EfficacyThe Journal of Experimental Medicine, 1997
- J774 Murine Macrophage-like Cell Interactions with Cryptococcus neoformans in the Presence and Absence of OpsoninsThe Journal of Infectious Diseases, 1996